LOGO
LOGO

Quick Facts

Primo Water Q4 Loss Narrows

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Primo Water Corp. (PRMW) Thursday reported fourth-quarter net loss of $7.0 million or $0.30 per share, compared to $10.7 million or $0.96 per share in the same period last year.

Adjusted net loss for the quarter was $2.5 million or $0.10 per share, compared to $1.4 million or $0.13 per share last year. On average, analysts polled by Thomson Reuters expected loss of $0.08 per share for the quarter. Analysts' estimates typically exclude one-time items.

Total sales surged 73.2 percent to $22.0 million from $12.7 million last year, driven mainly by water and dispenser sales. Wall Street analysts on a consensus estimated revenues of $22.08 million for the quarter.

Looking forward to the first quarter, the company expects loss in a range of $0.14 to $0.16 per share, adjusted loss of $0.07 to $0.09 per share, and net sales of $19.7 million to $21.4 million. Analysts currently expect earnings of $0.04 per share on revenues of $27.30 million for the quarter.

For the full year 2012, the company expects net income to be breakeven to $0.03 per share, adjusted net income of $0.07 to $0.12 per share, and net sales of $118.0 million to $126.0 million. Analysts currently estimate earnings of $0.26 per share, on revenues of $135.12 million for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19